Universal mass vaccination against rotavirus gastroenteritis: impact on hospitalization rates in austrian children

The Pediatric Infectious Disease Journal
Maria Paulke-KorinekHerwig Kollaritsch

Abstract

Since July 2007, rotavirus vaccinations have been subsidized in Austria for all children from the seventh week up to the sixth month of life. Vaccination coverage over the whole period was 72% with an increase to 87% in 2008. In a sentinel network including 11 pediatric hospital wards in Austria, data of children up to 15 years of age and hospitalized due to rotavirus gastroenteritis between January 2001 and December 2008 have been collected. The hospitalization rates of children up to 12 months of age with rotavirus gastroenteritis were 2066 x 10(-5) between 2001 and 2006 and decreased to 631 x 10(-5) in 2008. For children between 12 and 24 months of age the hospitalization rate decreased from 1822 x 10(-5) (2001-2006) to 1456 x 10(-5) in 2008. In children aged 2 to less than 5 years, incidence rates were 436 x10(-5) (2001-2006) and 461 x 10(-5) in 2008. In older children, the hospitalization rates remained unchanged. In the target population for the RV-vaccine, a decrease of hospitalization rates due to rotavirus gastroenteritis of 74% was observed compared to the era before the introduction of the vaccine. The field effectiveness of the vaccine was estimated between 61% and 98%, depending on assumptions about the vaccination...Continue Reading

References

Feb 27, 2001·The Pediatric Infectious Disease Journal·M FrühwirthI Mutz
Nov 29, 2001·Journal of Clinical Microbiology·B R EingJ E Kühn
Jan 5, 2002·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·I WilhelmiA Sánchez-Fauquier
Jan 6, 2006·The New England Journal of Medicine·Guillermo M Ruiz-PalaciosUNKNOWN Human Rotavirus Vaccine Study Group
Jan 6, 2006·The New England Journal of Medicine·Timo VesikariUNKNOWN Rotavirus Efficacy and Safety Trial (REST) Study Team
Jan 7, 2006·The Pediatric Infectious Disease Journal·Montse Soriano-GabarróThomas Verstraeten
Jul 1, 2006·Wiener klinische Wochenschrift·Pamela Rendi-WagnerHerwig Kollaritsch
Jul 25, 2006·Lancet·Roger I GlassJon R Gentsch
Sep 18, 2007·Vaccine·Franz X HeinzMichael Kundi
Apr 9, 2008·Expert Review of Vaccines·Lucia Helena de OliveiraJon Kim Andrus

❮ Previous
Next ❯

Citations

Jun 20, 2014·BMC Infectious Diseases·Salah Thabit Al AwaidyMegan A O'Brien
Apr 10, 2016·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jacqueline E TateUmesh D Parashar
Jul 23, 2014·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jacqueline E Tate, Umesh D Parashar
Mar 22, 2015·Vaccine·Emilie KarafillakisChristina Atchison
Mar 30, 2011·Vaccine·Arnaud GagneurUNKNOWN IVANHOE investigators
Sep 5, 2015·Infectious Disease Clinics of North America·Penelope H Dennehy
Aug 1, 2014·Clinical and Vaccine Immunology : CVI·Jean-Michel RouéArnaud Gagneur
Dec 14, 2011·Deutsches Ärzteblatt International·Miriam Wiese-PosseltFred Zepp
Apr 11, 2015·The Pediatric Infectious Disease Journal·Timo VesikariVytautas Usonis
Aug 21, 2010·The Pediatric Infectious Disease Journal·Judith Koch, Miriam Wiese-Posselt
Aug 21, 2013·The Pediatric Infectious Disease Journal·Kong Boo PhuaYanfang Liu
Jan 22, 2013·The Pediatric Infectious Disease Journal·Cornelia AdlhochJudith Koch
Mar 26, 2011·The Pediatric Infectious Disease Journal·Marc RaesBaudouin Standaert
Dec 23, 2011·Current Opinion in Pediatrics·Penelope H Dennehy
Jun 19, 2010·Wiener klinische Wochenschrift·Michael Kunze
Jun 1, 2010·Medicine·M Sánchez Conde
Aug 14, 2012·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·T Vesikari
Sep 16, 2010·European Journal of Pediatrics·Javier Diez-DomingoUNKNOWN SPRIK Rotavirus Study Group
Apr 19, 2011·European Journal of Pediatrics·Thomas HoffmannBirthe Hogh
Apr 29, 2011·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Renat LatipovElmira Flem
Aug 23, 2011·Expert Review of Vaccines·Jacqueline E Tate, Umesh D Parashar
Nov 17, 2011·Expert Review of Vaccines·Miguel O'RyanAlexandre C Linhares
Dec 20, 2011·Vaccine·Carlo GiaquintoTimo Vesikari
Nov 24, 2011·Human Vaccines·Catherine YenUmesh D Parashar
Jun 16, 2012·Human Vaccines & Immunotherapeutics·Chiara MameliGian Vincenzo Zuccotti
Jul 17, 2012·Indian Pediatrics·G KahnM Santosham
Jun 30, 2012·The Lancet Infectious Diseases·Manish M PatelUmesh D Parashar
Jul 4, 2012·Current Opinion in Virology·Ben A LopmanUmesh D Parashar
Jun 19, 2012·Expert Review of Anti-infective Therapy·Philippe Lepage, Anne Vergison
Sep 4, 2012·Vaccine·Terri B HydeUNKNOWN New Vaccine Introduction Impact Published Literature Working Group
Sep 11, 2012·Human Vaccines & Immunotherapeutics·Sandra Dudareva-VizuleOle Wichmann

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.